熊市中表现良好的板块与股票

作者：Xavier Brenner

来源：IB美国盈透证券

原文发表于美国时间2020-3-31

冠状病毒的全球大流行导致金融市场的震荡，在向上和向下两个方向均出现了历史性的波动。

随着政府采取封闭措施、经济抛锚以及公司争先恐后地提取信贷额度，股市受到整体性的冲击。

长达11年的美股历史性牛市也戛然而止。

截至3月24日，罗素3000指数较2月19日的高点下跌了约35%。标普500指数的跌幅为15%，道琼斯工业平均指数和纳斯达克综合指数分别下跌了18%与7.5%。

盎然绿意

不过在股市的大跌中，部分股票的表现截然不同。Bespoke投资集团统计出此类表现公司的两张图表。

部分医疗保健类股票表现良好。Bespoke投资集团指出，自2月19日市场创下历史新高后，Tocagen公司（代码：TOCA）和Vir Biotechnology公司（代码：VIR）的股价上涨了一倍。除此之外，16家其他公司的股票在同一时期也有着两位数的百分比涨幅。

从更广的市场角度来看，在消费必需品板块和非必须消费品板块的带领下，防御性股票表现良好。这些公司包括Waitr公司（WTRH），达美乐比萨（DPZ）以及Clorox公司（CLX）。

结论

市场波动不已，请谨慎应对并在对投资组合进行任何重大调整之前咨询您的财务顾问。

不过我认为，敏锐的投资者即便在熊市中也能发现机会。

这篇文章已被翻译成中文。原英文作者Xavier Brenner。如英文版本和中文版本之间有任何不一致，以英文版本为准。该文章中的分析仅为提供信息，不是也不应该被视为推销或招揽购买任何证券。文章中讨论的一般市场活动、行业或领域趋势、或其它基于广泛的经济或政治条件的内容，不应被解释为研究结果或投资建议。讨论中提及包括的特定证券、商品、货币、或其它产品均不构成IB推荐购买，出售或持有此类投资的建议。本材料不是也不意图针对个别客户的特定财务条件、投资目标或要求。在根据本材料采取行动之前，您应该考虑是否适合您的具体情况，并在必要时寻求专业建议。

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Interactive Advisors, an affiliate of Interactive Brokers LLC, and is being posted with permission from Interactive Advisors. The views expressed in this material are solely those of the author and/or Interactive Advisors and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.